Founded in Woburn, United States, Aphios is dedicated to pioneering green biotechnology and nanotechnology solutions. The company's core mission is to develop enabling drug delivery platforms and enhanced therapeutic products aimed at health maintenance, disease prevention, and the treatment of cancers, infectious diseases, and Central Nervous System (CNS) disorders. Aphios focuses on creating natural solutions for human health through its innovative technologies and products.
Aphios has garnered attention from notable investors and industry experts due to its groundbreaking work in biotech and nanotech. The company has achieved significant milestones in developing sustainable and effective therapeutic solutions. Its impact is evident in the advancement of green technology applications in medicine, contributing to more effective and environmentally friendly healthcare solutions.
